• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Catalog Number TGMR373720J
Device Problems Malposition of Device (2616); Patient-Device Incompatibility (2682)
Patient Problems Hematoma (1884); Low Blood Pressure/ Hypotension (1914); Perforation of Vessels (2135)
Event Date 10/10/2023
Event Type  Injury  
Manufacturer Narrative
H3: code "other" was selected as the medical device remains implanted.Return not possible.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
The following information was reported to gore: on (b)(6) 2023, this patient underwent an endovascular procedure for an enlarging thoracic aortic pseudoaneurysm which had developed after the aortic arch vascular graft replacement.Gore® tag® conformable thoracic stent graft with active control systems (ctag) were used for the procedure.The right femoral artery was cut down, and a tgmr373720j was delivered.Upon deployment, the device moved distally because the physician was not holding the handle and the shaft of the catheter in a steady manner.The hypotension was noted (approx.Diastolic bp 30~40mmhg), therefore, the physician immediately inserted another ctag (tgm454520j) to the distal end of the tgmr373720j, which recovered and stabilized the blood pressure.(approx.Maximal bp 100mmhg / diastolic bp 60mmhg).After all stent grafts were deployed, a hematoma was noted within the aneurysm at the end of the procedure.It was considered that the tgmr373720j could have damaged the vessel when it moved during deployment, causing the hypotension due to bleeding and subsequent hematoma.No further treatment was provided, and the patient tolerated the procedure.On the same day after the procedure, a proximal type i endoleak was confirmed.On (b)(6) 2023, a reintervention was performed to treat the proximal type i endoleak.An additional ctag was added to the proximal end of the previously implanted stent grafts.The proximal type i endoleak was resolved.The patient tolerated the procedure.
 
Manufacturer Narrative
H6: a review of the manufacturing records for the device verified that the lot met all pre-release specifications.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY SPRINGS B/P
3450 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
hiroko sakamiya
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key18044756
MDR Text Key327018001
Report Number2017233-2023-04374
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
P040043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 12/19/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberTGMR373720J
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 10/10/2023
Initial Date FDA Received10/31/2023
Supplement Dates Manufacturer Received10/10/2023
Supplement Dates FDA Received12/18/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured06/01/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age75 YR
Patient SexFemale
-
-